NHS Wales Joint Commissioning Committee Signs Agreement to Strengthen Medicines Management Across Wales

The NHS Wales Joint Commissioning Committee (NWJCC) has signed a Memorandum of Understanding (MoU) with the All-Wales Therapeutics and Toxicology Centre (AWTTC) to strengthen collaboration on how medicines are assessed and managed across Wales.  

Signed in November, the agreement sets out a framework for joint working that will support better-informed decisions and ensure treatments are safe, effective and sustainable. 

The MoU brings together two organisations with complementary roles; NWJCC commissions national services on behalf of all seven health boards, making sure care is high-quality, equitable and offers value for the population of Wales. AWTTC is a national centre that provides expert advice on medicines, including how they should be used safely and effectively, and evaluates new treatments to understand their benefits and risks. By working together, NWJCC and AWTTC can share knowledge and resources to make better-informed decisions for patients. 

Iolo Doull, Director of Medical for NWJCC, said: "This agreement marks a significant step in creating a more collaborative approach to medicines management in Wales.  

“Working closely with AWTTC will allow us to respond quickly to emerging treatments and ensure decisions are consistent and evidence based. Ultimately, this collaboration will help deliver better outcomes for patients and make the best use of NHS resources.” 

This partnership reflects NWJCC’s values of Fostering Collaboration and Striving for Excellence by building stronger relationships across NHS Wales and sharing expertise to improve decision-making. It also supports the ambitions of A Healthier Wales, the Welsh Government’s long-term plan for health and social care. That strategy focuses on prevention, integration and quality, and this agreement is a practical step toward turning that vision into reality.  

Through this collaboration, NWJCC and AWTTC will focus on medicines optimisation processes and support the understanding and development of complex pathways, ensuring that commissioned services are sustainable and value based.